Outset Medical to Present at Upcoming Investor Conferences

Rhea-AI Summary

Outset Medical, Inc. (NASDAQ: OM), a pioneering medical technology firm, announced its participation in two upcoming investor conferences. The Bank of America Securities 2023 Health Care Conference is scheduled for May 9, 2023, at 1:40 PM PT, while the RBC Capital Markets Global Healthcare Conference will take place on May 17, 2023, at 5:00 AM PT. Live and archived webcasts of these events will be accessible via the Outset Investors' website.

Outset's flagship product, the Tablo Hemodialysis System, aims to streamline dialysis, making it more accessible and efficient for patients and providers. This innovative system integrates water purification and on-demand dialysate production, positioning it as a versatile solution for dialysis care.

SAN JOSE, Calif.--(BUSINESS WIRE)-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in fireside chats at two upcoming investor conferences. Outset will participate in the Bank of America Securities 2023 Health Care Conference on Tuesday, May 9, 2023, and the RBC Capital Markets Global Healthcare Conference on Wednesday, May 17, 2023.

Event: Bank of America Securities 2023 Health Care Conference
Date: Tuesday, May 9, 2023
Time: 1:40pm PT / 4:40pm ET

Event: RBC Capital Markets Global Healthcare Conference
Date: Wednesday, May 17, 2023
Time: 5:00am PT / 8:00am ET

Live and archived webcasts of the fireside chats will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230425005155/en/

Jim Mazzola

Vice President, Investor Relations

jmazzola@outsetmedical.com

Brian Johnston

Gilmartin Group

(332) 895-3222

investors@outsetmedical.com

Source: Outset Medical, Inc.

FAQ

What is the date of the Bank of America Securities 2023 Health Care Conference for Outset Medical (OM)?

The Bank of America Securities 2023 Health Care Conference for Outset Medical (OM) is on May 9, 2023.

When will Outset Medical (OM) participate in the RBC Capital Markets Global Healthcare Conference?

Outset Medical (OM) will participate in the RBC Capital Markets Global Healthcare Conference on May 17, 2023.

What time is Outset Medical's (OM) presentation at the Health Care Conference on May 9, 2023?

Outset Medical's (OM) presentation at the Health Care Conference on May 9, 2023, is at 1:40 PM PT.

Where can I find the webcast of Outset Medical's (OM) investor conference presentations?

The webcast of Outset Medical's (OM) investor conference presentations can be found on their Investors' website at https://investors.outsetmedical.com/.

What technology does Outset Medical (OM) offer for dialysis treatment?

Outset Medical (OM) offers the Tablo Hemodialysis System, which reduces the cost and complexity of dialysis treatment.